SCHEDULE: TPG Entities Report 7.8% Stake in Ceribell, Inc.

TPG GP A, LLC, along with James G. Coulter and Jon Winkelried, has reported a joint beneficial ownership of 2,975,566 shares, representing 7.8% of Ceribell, Inc.'s common stock.

Summary

• TPG GP A, LLC, James G. Coulter, and Jon Winkelried have jointly filed a Schedule 13G, indicating their beneficial ownership of Ceribell, Inc. common stock.
• The total number of shares beneficially owned by these reporting persons is 2,975,566.
• This holding represents 7.8% of the total outstanding shares of Ceribell, Inc. common stock.
• The ownership is based on 38,378,101 shares outstanding as of August 6, 2026, as reported in Ceribell's Form 10-Q filed on August 10, 2026.
• TPG GP A, LLC is a Delaware limited liability company, and Messrs. Coulter and Winkelried are U.S. citizens.
• The filing is an amendment (Amendment No. 1) to a previous filing.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as neutral to slightly positive, indicating a significant but stable ownership stake without immediate aggressive action.

Positives

• Significant ownership stake (7.8%) by TPG entities and associated individuals, suggesting confidence in Ceribell's long-term prospects.
• Joint filing indicates a coordinated and potentially stable investment strategy.

Negatives

• The filing is a Schedule 13G, which typically indicates passive investment, rather than a Schedule 13D, which would suggest a more active or activist stake.
• No new capital is being injected or raised as per this filing.

Risks

• While TPG entities hold a significant stake, the passive nature of a 13G filing means they are not actively seeking to control or influence the company's management, which could limit their ability to drive change if needed.
• The filing does not provide details on the specific investment strategy or future intentions of the reporting persons beyond maintaining their current stake.

Future Outlook

The filing itself does not contain forward-looking statements or guidance from Ceribell, Inc. It solely reports on the ownership stake of TPG entities and associated individuals.

Industry Context

StockSavvy.ai notes that significant stakes reported via Schedule 13G filings by major investment firms like TPG often signal a belief in the target company's sector and potential for growth, particularly in technology or healthcare sectors where Ceribell operates.

Comparison to Industry Standards

• A 7.8% stake is a substantial minority holding, common for institutional investors in growth-stage companies. For comparison, similar stakes in the medical device sector might range from 5% to 15% for significant institutional investors.
• The passive nature of the filing (13G) is standard for investment funds that do not intend to influence company operations directly, differentiating them from activist investors who typically file 13D.

Stakeholder Impact

• Shareholders: The continued significant holding by TPG may provide a degree of stability and signal investor confidence, potentially influencing market perception.
• Management: The passive nature of the filing suggests no immediate pressure for strategic changes from these shareholders, allowing current management to continue its operational plans.

Next Steps

• The reporting persons will continue to hold their shares in Ceribell, Inc.
• Future filings will be made if there are material changes in beneficial ownership.

Key Dates

Keywords

Ceribell, TPG, Schedule 13G, Beneficial Ownership, Investment, Shareholder, Equity Stake